A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia

Completed · Phase 1/Phase 2

Conditions studied: X-linked Hypophosphatemia

In brief

The primary purpose of this study is to assess the safety and efficacy of repeated subcutaneous (SC) injections of KRN23 in adult subjects with X-Linked Hypophosphatemia (XLH). A Bone Substudy will evaluate the effects of single-blind KRN23 versus Placebo on bone mineral density and bone quality.

Key facts

Study ID

NCT01340482

Run by

Kyowa Kirin Co., Ltd.

People needed

29

Starts

2011-04-01

Expected to finish

2013-10-01

Last updated by the study team

2024-06-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of California, San Francisco Medical Center — San Francisco, California, United States
• Yale University School of Medicine — New Haven, Connecticut, United States
• Clinical Research Center, Indiana University School of Medicine — Indianapolis, Indiana, United States
• Duke Clinical Research Unit — Durham, North Carolina, United States
• University of Texas Health Science Center at Houston — Houston, Texas, United States
• Shriners Hospital for Children - Canada — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.